NEXT Financial Group, Inc - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
NEXT Financial Group, Inc ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$72,000
-10.0%
609
+2.2%
0.01%
-16.7%
Q3 2021$80,000
-27.9%
596
-13.4%
0.01%
-33.3%
Q2 2021$111,000
+27.6%
688
-36.6%
0.01%
+12.5%
Q1 2021$87,000
+1350.0%
1,086
+782.9%
0.01%
+700.0%
Q4 2020$6,000
+200.0%
123
+23.0%
0.00%
Q3 2020$2,000
+100.0%
1000.0%0.00%
Q1 2020$1,0000.0%1000.0%0.00%
Q4 2019$1,0000.0%1000.0%0.00%
Q3 2019$1,000
-50.0%
1000.0%0.00%
Q2 2019$2,000
+100.0%
100
+69.5%
0.00%
Q4 2018$1,000590.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders